Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
The objective is to carry out a randomized blinded placebo-controlled trial of inhaled Albuterol as an early therapy for patients with decompensated Congestive Heart Failure. Compared to placebo, inhaled Albuterol will improve oxygenation and decrease the need for non-invasive ventilation in patients with Cardiogenic Pulmonary Edema.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age 18-65 with shortness of breath and history of CHF
pulmonary edema on chest xr
You may not be if
pregnancy
clinical or ekg changes to suggest acute coronary syndrome
